Close Menu

NEW YORK – Luminex said today that the US Food and Drug Administration has granted 510(k) clearance for its the real-time PCR-based Aries MRSA Assay running on its Aries sample-to-answer system.

The FDA has cleared the test for the direct detection of methicillin-resistant Staphylococcus aureus DNA from nasal swabs in patients at risk for nasal colonization.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.